Sham transcranial photobiomodulation

DEVICE4 trials

Sponsors

Massachusetts General Hospital, Francisco Gonzalez-Lima, PhD, Uskudar University

Conditions

AMCI - Amnestic Mild Cognitive ImpairmentAttention DeficitAttention Deficit Hyperactivity DisorderAttention DifficultiesCognitive DeficitDown SyndromeWellness

Unknown Phase

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

Active, not recruitingNCT04668001

Massachusetts General HospitalDown Syndrome

Start: 2021-10-19End: 2024-09-01Updated: 2024-05-31

Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation

RecruitingNCT05802680

Francisco Gonzalez-Lima, PhDAttention Deficit Hyperactivity Disorder, Attention Difficulties, Attention Deficit +2

Start: 2022-02-09End: 2027-02-01Target: 500Updated: 2026-06-22

Effects of Transcranial Photobiomodulation in ADHD

RecruitingNCT07203092

Francisco Gonzalez-Lima, PhDAttention Deficit Hyperactivity Disorder

Start: 2025-09-01End: 2027-12-01Target: 140Updated: 2026-06-22

Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment

RecruitingNCT07287527

Uskudar UniversityAMCI - Amnestic Mild Cognitive Impairment

Start: 2024-03-30End: 2026-10-31Target: 60Updated: 2025-12-17

Related Papers

Transcranial photobiomodulation improves prefrontal oxygenation and impulse control in adults with ADHD: a randomized controlled trial

BMC Psychiatry2026-07-14